Cargando…

A scalable and high yielding SARS-CoV-2 spike protein receptor binding domain production process

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike protein is of interest for the development of vaccines and therapeutics against COVID-19. Vaccines are designed to raise an immune response against the spike protein. Other therapies attempt to block the interaction of the spike...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riguero, Valeria, Delmar, Jared, Dippel, Andrew, McTamney, Patrick, Luo, Ethan, Martinez, Antonio, Ren, Kuishu, van Dyk, Nydia, O'Connor, Ellen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Inc. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890279/ https://www.ncbi.nlm.nih.gov/pubmed/36736512 http://dx.doi.org/10.1016/j.pep.2023.106241

Ejemplares similares

Profile of patients with chemical injury and sensitivity.
por: Ziem, G, et al.
Publicado: (1997)

Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice
por: Cayatte, Corinne, et al.
Publicado: (2017)

Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance Monitoring
por: Brady, Tyler, et al.
Publicado: (2022)

Scalable, Bayesian, multi-electrode spike sorting
por: Prentice, Jason, et al.
Publicado: (2010)

Scalable high yield exfoliation for monolayer nanosheets
por: Wang, Zhuyuan, et al.
Publicado: (2023)

Toward robust and scalable deep spiking reinforcement learning
por: Akl, Mahmoud, et al.
Publicado: (2023)

Potential yields and emission reductions of biojet fuels produced via hydrotreatment of biocrudes produced through direct thermochemical liquefaction
por: van Dyk, Susan, et al.
Publicado: (2019)

1355. The SARS-CoV-2 Monoclonal Antibody AZD3152 Potently Neutralizes Historical and Emerging Variants and is Being Developed for the Prevention and Treatment of COVID-19 in High-risk Individuals
por: Francica, Joseph R, et al.
Publicado: (2023)

Fast, Scalable, Bayesian Spike Identification for Multi-Electrode Arrays
por: Prentice, Jason S., et al.
Publicado: (2011)

Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
por: Chi, Xiaojing, et al.
Publicado: (2020)

Structural Requirements and Plasticity of Receptor-Binding Domain in Human Coronavirus Spike
por: Li, Yajuan, et al.
Publicado: (2022)

Communication Sparsity in Distributed Spiking Neural Network Simulations to Improve Scalability
por: Fernandez-Musoles, Carlos, et al.
Publicado: (2019)

Scalable and accurate method for neuronal ensemble detection in spiking neural networks
por: Herzog, Rubén, et al.
Publicado: (2021)

Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera
por: Yassine, Hadi M., et al.
Publicado: (2018)

Structural and genetic basis for development of broadly neutralizing influenza antibodies
por: Lingwood, Daniel, et al.
Publicado: (2012)

S373P Mutation Stabilizes the Receptor-Binding Domain of the Spike Protein in Omicron and Promotes Binding
por: Zheng, Bin, et al.
Publicado: (2023)

A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein
por: Joyce, M. Gordon, et al.
Publicado: (2020)

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies
por: Spencer, Alexandra J, et al.
Publicado: (2022)

Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered Komagataella phaffii
por: Dalvie, Neil C., et al.
Publicado: (2021)

Scalable, methanol‐free manufacturing of the SARS‐CoV‐2 receptor‐binding domain in engineered Komagataella phaffii
por: Dalvie, Neil C., et al.
Publicado: (2021)

Crystal structure of the receptor binding domain of the spike glycoprotein of human betacoronavirus HKU1
por: Ou, Xiuyuan, et al.
Publicado: (2017)

Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation
por: Henderson, Rory, et al.
Publicado: (2020)

Crystallization and Structural Determination of the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein
por: Zhou, Haixia, et al.
Publicado: (2019)

Predicting the receptor-binding domain usage of the coronavirus based on kmer frequency on spike protein
por: Zhu, Zhaozhong, et al.
Publicado: (2018)

The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
por: Dokainish, Hisham M, et al.
Publicado: (2022)

The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint
por: Guo, Hua, et al.
Publicado: (2022)

Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein
por: Verma, Saroj, et al.
Publicado: (2022)

Conformational Dynamics of the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
por: Mamchur, Aleksandra A., et al.
Publicado: (2022)

Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding
por: Bozdaganyan, Marine E., et al.
Publicado: (2022)

Scalable Sparse Testing Genomic Selection Strategy for Early Yield Testing Stage
por: Atanda, Sikiru Adeniyi, et al.
Publicado: (2021)

Extremely Scalable Spiking Neuronal Network Simulation Code: From Laptops to Exascale Computers
por: Jordan, Jakob, et al.
Publicado: (2018)

A scalable implementation of the recursive least-squares algorithm for training spiking neural networks
por: Arthur, Benjamin J., et al.
Publicado: (2023)

Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein
por: Li, Bingqian, et al.
Publicado: (2021)

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction
por: Eka Saputri, Meliana, et al.
Publicado: (2022)

Crosstalk among hormones in barley spike contributes to the yield
por: Youssef, Helmy M., et al.
Publicado: (2019)

High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
por: Esparza, Thomas J., et al.
Publicado: (2020)

Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization
por: Hauser, Blake M., et al.
Publicado: (2022)

Binding behavior of spike protein and receptor binding domain of the SARS-CoV-2 virus at different environmental conditions
por: Zhang, Meiyi, et al.
Publicado: (2022)

Binding Interactions between Receptor-Binding Domain of Spike Protein and Human Angiotensin Converting Enzyme-2 in Omicron Variant
por: Jawad, Bahaa, et al.
Publicado: (2022)

Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
por: Hussain, Arif, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_esu8kl1q6j34194r9o8aeeh4bg